Fact CheckerSign in

NCT07163923Completed

MIND Diet in Relation to Malnutrition and Depression in AD

The Role of the MIND Diet in Alzheimer's Disease Patients: A Case-Control Study on Malnutrition and Depression

Source: ClinicalTrials.gov · Last updated 9 Sept 2025

Brief summary (registry, in English)

The aim of this study was to examine the association between depression, malnutrition, and the Mediterranean-Dietary Approaches to Stop Hypertension Diet Intervention for Neurodegenerative Delay (MIND) diet in Alzheimer's disease patients. This study included 30 patients with Alzheimer's disease (AD) and 30 healthy controls. A questionnaire form including sociodemographic characteristics was applied to the individuals. In addition, anthropometric measurements, biochemical parameters, nutritional status (Food Frequency Questionnaire (FFQ), Mini Nutritional Assessment-Short Form (MNA-SF), Geriatric Nutritional Risk Index (GNRI) and MIND diet scores) and mental health status (Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI)).

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
28 Aug 2025
Start date
15 Jun 2024
Primary completion date
15 Oct 2024
Lead sponsor
Abant Izzet Baysal University
NCT number
NCT07163923

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From 15 Jun 2024 to the primary completion date, 15 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Chronic inflammatory diseases
  • Bipolar disorder
  • Neoplastic disorders
  • End-stage liver disease
  • End-stage kidney disease

Other

  • Schizophrenia
  • Amputations

Who the study is looking for

  • Patients aged over 60 years.
  • Diagnosed with Alzheimer's disease (AD) (for AD group)
  • Able to communicate with themselves or their companions
  • Healthy volunteers without systemic or neurological diseases (for control group)
  • Matching criteria: Age, gender, smoking status, and alcohol use

Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bolu Abant İzzet Baysal University, Faculty of Health Sciences
Coordinator of this site? Confirm its status
BoluTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.